Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04376216 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prednisolone Treatment in Acute Interstitial Nephritis

Study acronym: PRAISE
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 30, 2020 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 56 words
    • Secondary endpoints: 4 to 8
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Prospective randomized trial with a primary objective to investigate the effect ofprdenisolone treatment in acute interstitial nephritis
Trial Details
NCT Number NCT04376216
Lead Sponsor Region MidtJylland Denmark
Collaborators: Aarhus University Hospital, Odense University Hospital
Conditions
(from sponsor)		 Acute Tubulo-Interstitial Nephritis
Related terms Acute Tubulointerstitial Nephritis
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov